Lissun raises $5.8M Series A to grow child development centres
What's the deal? Lissun, a Gurugram-based health-tech company for children with developmental delays and special needs, has raised 480,000,000 INR ($5.76 million) in a Series A round led by Colossa VenturesDealroom has a profile for this one. Try Dealroom →. Physis CapitalDealroom has a profile for this one. Try Dealroom → joined, alongside existing backers RPSG CapitalDealroom has a profile for this one. Try Dealroom → Ventures, IvyCap VenturesDealroom has a profile for this one. Try Dealroom →, RainmatterDealroom has a profile for this one. Try Dealroom →, Multiply VenturesDealroom has a profile for this one. Try Dealroom →, and SucSEED VenturesDealroom has a profile for this one. Try Dealroom →.
What's the endgame? Lissun runs Sunshine by LissunDealroom has a profile for this one. Try Dealroom →, a network of child development centres across India offering therapy for conditions such as autism, attention deficit hyperactivity disorder, and speech delays. It also builds AI-powered tools for therapists and parents.
Where's the money going? Lissun will expand Sunshine centres in key cities, build AI-led solutions on its proprietary technology and data, and strengthen clinical processes across the network.
Why AI? "Today, our AI tools largely support therapists and parents, but the bigger opportunity is building AI-led solutions on our own proprietary technology and data," said Krishna Veer Singh, co-founder and chief executive officer. He pointed to "the potential to reach millions of children across India who lack access to quality developmental care."
The signal: At $5.76 million, the round sits in the 24th percentile by amount — modest against the broader funding field, but it channels capital into a specialised, underserved niche. It signals investor appetite for health-tech that pairs clinical services with proprietary data as a foundation for AI.
Read more: Tech Observer Magazine
Image credit: Lissun
